Improving Tumor Oxygenation in Cervical Cancer

NCT00257829 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped This study was closed due to lack of funding.

Conditions

Cervical Cancer

Interventions

DRUG: Methazolamide
DRUG: Cisplatin

Sponsor

University of California, Irvine